|1.||Amiji, Mansoor M: 3 articles (05/2008 - 04/2005)|
|2.||Seiden, Michael V: 2 articles (05/2008 - 10/2007)|
|3.||Devalapally, Harikrishna: 2 articles (05/2008 - 10/2007)|
|4.||Duan, Zhenfeng: 2 articles (05/2008 - 10/2007)|
|5.||Barbieri, A: 1 article (04/2013)|
|6.||Palma, G: 1 article (04/2013)|
|7.||Quaglia, F: 1 article (04/2013)|
|8.||Leone, N: 1 article (04/2013)|
|9.||Siracusano, G: 1 article (04/2013)|
|10.||Arra, C: 1 article (04/2013)|
10/15/2007 - "PTX and CER were administered intravenously either as a single agent or in combination in aqueous solution and in PEO-PCL nanoparticles to the tumor-bearing mice. "
04/11/2005 - "PEO-PCL nanoparticles exhibited significantly increased level of accumulation of the drug within tumor with time as well as extended their presence in the systemic circulation than the controls (unmodified nanoparticles or the solution form). "
07/01/2012 - "In this study, stealth nanoparticles of PEO/PCL block copolymers for passive targeting of docetaxel to solid tumors were developed using a novel technique. "
04/10/2013 - "Superior antitumor activity of ZnPc/DTX-loaded NPs as compared to DTX-loaded NPs was confirmed in an animal model of orthotopic amelanotic melanoma, thus pointing to the application of PEO-PCL NPs in the combined chemo-photodynamic therapy of cancer."
|2.||Ovarian Neoplasms (Ovarian Cancer)
|3.||Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
|4.||Amelanotic Melanoma (Amelanotic Melanomas)
|5.||Melanoma (Melanoma, Malignant)
|4.||Ethylene Oxide (Oxirane)
|1.||Photochemotherapy (Photodynamic Therapy)